Confirmation of a novel recurrent association: BCR-ABL t(9;22) and t(19;21)

Cancer Genetics and Cytogenetics

Volumn 179, Issue 2, 2007, Pages 127-131

  Struski, Stéphanie ^a,b   Hélias, Catherine ^b   Gervais, Carine ^b   Leymarie, Vincent ^b   Audhuy, Bruno ^c   Moskovtchenko, Philippe ^c   Lutz, Patrick ^b   Gaub, Marie Pierre ^b   Lessard, Michel ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

^c Hôpitaux Civils   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AGED; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER RECURRENCE; CASE REPORT; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENE PROBE; GENETIC ASSOCIATION; HUMAN; LEUKEMIA RELAPSE; MALE; MYELOPROLIFERATIVE DISORDER; ONCOGENE BCR ABL; PRIORITY JOURNAL;

ADOLESCENT; AGED; BURKITT LYMPHOMA; CHROMOSOMES, HUMAN, PAIR 19; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MYELOPROLIFERATIVE DISORDERS; TRANSLOCATION, GENETIC;

BACTERIA (MICROORGANISMS);

EID: 36249004979     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.08.004     Document Type: Article

References (16)

1. Schilling G., Dierlamm J., Penas E.M., Hinz K., Seeger D., and Hossfeld D.K. Dicentric (19;21)(p13;p13), a novel chromosomal abnormality occurring in a case of Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer Genet Cytogenet 152 (2004) 129-131
2. Panani A.D., Dervenoulas J., Ferti A., and Raptis S. Acute lymphoblastic leukemia with a variant Philadelphia translocation, der(9), and der(19) chromosomes. Cancer Genet Cytogenet 80 (1995) 162-164
3. Bene M.C., Castoldi G., Knapp W., Ludwig W.D., Matutes E., Orfao A., and van't Veer M.B. European Group for the Immunological Characterization of Leukemias (EGIL). Proposals for the immunological classification of acute leukemias. Leukemia 9 (1995) 1783-1786
4. ISCN 2005: an international system for human cytogenetic nomenclature (2005). In: Shaffer L.G., and Tommerup N. (Eds) (2005), S. Karger, Basel
5. Guillaud-Bataille M., Valent A., Soularue P., Perot C., Inda M.M., Receveur A., Smaili S., Roest Crollius H., Benard J., Bernheim A., Gidrol X., and Danglot G. Detecting single DNA copy number variations in complex genomes using one nanogram of starting DNA and BAC-array CGH. Nucleic Acids Res 32 (2004) e112
6. Gabert J., Beillard E., van der Velden V.H., Bi W., Grimwade D., Pallisgaard N., Barbany G., Cazzaniga G., Cayuela J.M., Cave H., Pane F., Aerts J.L., De Micheli D., Thirion X., Pradel V., Gonzalez M., Viehmann S., Malec M., Saglio G., and van Dongen J.J. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia: a Europe Against Cancer program. Leukema 17 (2003) 2318-2357
7. Lim T.H., Tien S.L., Lim P., and Lim A.S.T. The incidence and patterns of BCR/ABL rearrangements in chronic myeloid leukaemia (CML) using fluorescence in situ hybridisation (FISH). Ann Acad Med Singapore 34 (2005) 533-538
8. Monma F., Nishii K., Yamamori S., Hosokai N., Nakazaki T., Lorenzo V F., Usui E., Sakakura M., Miyashita H., Fujieda A., Ohishi K., Katayama N., and Shiku H. Fluorescent in situ hybridization analysis of Philadelphia chromosome-negative chronic myeloid leukemia with the bcr/abl fusion gene. Int J Hematol 80 (2004) 155-158
9. Morel F., Herry A., Le Bris M.J., Morice P., Bouquard P., Abgrall J.F., Berthou C., and De Braekeleer M. Contribution of fluorescence in situ hybridization analyses to the characterization of masked and complex Philadelphia chromosome translocations in chronic myelocytic leukemia. Cancer Genet Cytogenet 147 (2003) 115-120
10. Morris C.M., Heisterkamp N., Kennedy M.A., Fitzgerald P.H., and Groffen J. Ph-negative chronic myeloid leukemia: molecular analysis of ABL insertion into M-BCR on chromosome 22. Blood 76 (1990) 1812-1818
11. Valle L., Fernández V., Pérez-Pons C., Sánchez F.G., Benítez J., and Urioste M. Generation of the BCR/ABL fusion gene in a Philadelphia chromosome-negative chronic myeloid leukaemia: insertion of 5.6 Mb of 9q34 into the BCR region of chromosome 22. Hematol Oncol 24 (2006) 86-88
12. Kadam P.R., Nanjangud G.J., Advani S.H., Nair C., Banavali S., Gopal R., and Saikia T. Chromosomal characteristics of chronic and blastic phase of chronic myeloid leukemia: a study of 100 patients in India. Cancer Genet Cytogenet 51 (1991) 167-181
13. Berger R., Busson M., and Romana S.P. A cryptic chromosome 19 abnormality in a patient with Ph-positive acute lymphoblastic leukemia. Cancer Genet Cytogenet 165 (2006) 79-80
14. Suzuki K., Sugawara T., Kowata S., Utsugizawa T., Ito S., Murai K., and Ishida Y. Uncommon karyotypic abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia. Cancer Genet Cytogenet 150 (2004) 159-163
15. Griffin T.C., Tomlinson G.E., Raimondi S.C., Sandoval C., Timmons C.F., Rosenfield C., Carroll A.J., and Schneider N.R. Childhood acute lymphoblastic leukemia with both t(1;19) and t(9;22). Leukemia 6 (1992) 535-540
16. Luo R.T., Lavau C., Du C., Simone F., Polak P.E., Kawamata S., and Thirman M.J. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis. Mol Cell Biol 21 (2001) 5678-5687